FDA anticipates disruptions, shortages as China outbreak plays out

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally. The agency has contacted hundreds of drug and devicemakers, and, so far, the links of the supply chain have held but will take all available measures if disruptions appear.